You are here: vision-research.eu » News

News

Germany’s prestigious Max Planck Society conducts huge bullying survey

Thousands of employees took part in social study after high-profile bullying scandals emerged last year.

Longer duration of statin use linked to lower risk for glaucoma

Jae H. Kang, Sc.D., from Brigham and Women's Hospital in Boston, and colleagues evaluated the association between elevated cholesterol levels and statin use and incident POAG among participants.

Institute of Ophthalmology, Moorfields and Peking University sign MoU for collaborative education

UCL Institute of Ophthalmology and its strategic partner, Moorfields Eye Hospital, have signed a Memorandum of Understanding with Peking University Health Science Center.

Springer Nature journals unify their policy to encourage preprint sharing

Recognizing the benefits, we move from merely supporting the use of preprint servers to promoting it.

New treatment for severe dry eye disease promising in early clinical trials

Participants in a phase I/II clinical trial of a new enzyme-based treatment for severe dry eye disease experienced reduced signs of disease and discomfort, according to a paper in Translational Vision Science and Technology.

LED light can damage eyes, health authority warns

The "blue light" in LED lighting can damage the eye's retina and disturb natural sleep rhythms, France's government-run health watchdog said this week.

Research suggests revision to common view on how retinal cells in mammals process light

Johns Hopkins Medicine scientists say that new experiments with mouse eye tissues strongly suggest that a longstanding "textbook concept" about the way a mammal's retina processes light needs a rewrite.

Junior researchers are losing out by ghostwriting peer reviews

Graduate students and postdocs who produce reviews under a senior colleague’s name receive no credit or acknowledgement for their work, and miss a chance to become acquainted with journal editors.

Study shows drug reduces risk of relapse with neuromyelitis optica

The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with neuromyelitis optica spectrum disorder (NMOSD).

Indonesia tops open-access publishing charts

Countries in southeast Asia, Africa and South America lead the way on free-to-read literature.

Aging baby boomers push sky high incidence of shingles of the eye

More Americans are being diagnosed with eye complications of shingles, but older adults can call the shots on whether they are protected from the painful rash that can cost them their eyesight.

US $244 billion lost annually because people don't have spectacles to correct myopia

Vision impairment caused by uncorrected myopia cost the global economy an estimated US$244 billion in lost productivity in 2015, according to a new study published in the March print issue of the scientific journal Ophthalmology.

Patients satisfied with oral sedation for cataract surgery

Using oral sedation during cataract surgery does not negatively impact patient satisfaction compared with using an intravenous (IV) sedative, according to a study published online April 16 in Ophthalmology.

Being a PhD student shouldn’t be bad for your health

The first international meeting on postgraduate mental health opens this week, but much more is needed to solve academia’s crisis.

Personalized 'Eye-in-a-Dish' models reveal genetic underpinnings of macular degeneration

Using stem cells derived from six people, University of California San Diego School of Medicine researchers recapitulated retinal cells in the lab.